Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2510]

Incidence rates of some cancer types have risen in people under age 50

Incidence rates of some cancer types have risen in people under age 50

Advanced imaging and targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

Advanced imaging and targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

Exosomal lnc-TAF12–2:1 identified as a novel diagnostic and therapeutic biomarker in bladder cancer

Exosomal lnc-TAF12–2:1 identified as a novel diagnostic and therapeutic biomarker in bladder cancer

Study finds structural barriers may prevent cancer care for people living with HIV

Study finds structural barriers may prevent cancer care for people living with HIV

Scientists develop super strong antibodies for new cancer treatment

Scientists develop super strong antibodies for new cancer treatment

Cancer therapies: AI-based image analysis detects early organ damage

Cancer therapies: AI-based image analysis detects early organ damage

TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancer

TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits...

TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC

TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk...

More men with prostate cancer are avoiding unnecessary surgery

More men with prostate cancer are avoiding unnecessary surgery

Nivolumab subcutaneous formulation given approval across multiple solid tumour types in the UK

Nivolumab subcutaneous formulation given approval across multiple solid tumour types in the UK

More from ecancer